FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of general formula (I) or a hydrate thereof, where R is (C1-C3) alkyl, and A is the following formula:
or ,
provided that the general formula (I) includes tautomers with hydrogen in different positions of the imidazole ring. Invention also relates to a pharmaceutical composition for treating a bacterial infectious disease, where the bacterial infectious disease is caused by gram-positive bacteria, selected from species of genus Staphylococcus, Streptococcus, Enterococcus and Clostridium, or gram-negative bacteria Neisseria gonorrhoeae, based on said compound.
EFFECT: technical result is obtaining a novel compound which can be used in medicine for treating bacterial infectious diseases.
15 cl, 9 dwg, 5 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF | 2014 |
|
RU2621709C2 |
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
AZAADAMANTANE DERIVATIVES AND METHODS FOR APPLYING | 2007 |
|
RU2450002C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
P38 KINASE-INHIBITING AGENTS | 2010 |
|
RU2532376C2 |
COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING CFTR ACTIVITY | 2015 |
|
RU2767460C2 |
SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE DERIVATIVES OF PYRIMIDINES, COMPOSITIONS THEREOF AND METHODS OF TREATING USE THEREOF | 2012 |
|
RU2697712C2 |
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2820150C2 |
Authors
Dates
2020-12-04—Published
2016-09-28—Filed